COVID-19 after kidney transplantation: Early outcomes and renal function following antiviral treatmentArticle Published on 2021-03-012023-07-02 Journal: International Journal of Infectious Diseases [Category] SARS, [키워드] Antiretrovirals complications Kidney injury Kidney transplantation Treatment [DOI] 10.1016/j.ijid.2021.01.023 PMC 바로가기
Impact of a COVID-19 National Lockdown on Integrated Care for Hypertension and HIVCOVID-19 국가 봉쇄가 고혈압 및 HIV 통합 치료에 미치는 영향Original Research Published on 2021-02-042022-09-11 Journal: Global Heart [Category] MERS, 치료제, [키워드] Access to care access to medicines anticipated antiretroviral Antiretrovirals chronic condition chronic conditions Clinical outcome clinical outcomes Cohort COVID-19 evaluate Government health facilities HIV HIV clinics hypertension Impact limit lockdown lockdowns measure Medicine Medicines motor vehicle offered open outcome Patient people with HIV public health remained reported spread of COVID-19 Uganda [DOI] 10.5334/gh.928 PMC 바로가기 [Article Type] Original Research
Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms?Original Paper Published on 2020-09-282022-11-01 Journal: Epidemiology and Infection [Category] COVID-19, SARS, [키워드] 2019 novel coronavirus disease 95% CI age Antiretrovirals association body-mass Brazil can be used confirmed case confounder Contact coronavirus coronavirus disease cough COVID-19 COVID-19-related symptom COVID-19-related symptoms drug flu-like Follow-up headache help identify individual individuals Influenza, Human majority men morbidity outbreak Pandemics pre-exposure prophylaxis (PrEP) Prevent Prophylaxis protective effect SARS-CoV-2 SARS-COV-2 infection social distancing the SARS-CoV-2 WhatsApp [DOI] 10.1017/S0950268820002253 PMC 바로가기 [Article Type] Original Paper
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile VirusPharmacology Published on 2020-08-262022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] ACE2 receptor acting administration angiotensin-converting enzyme 2 receptors Antibiotics Antimalarial drugs Antiretrovirals antiviral activity approach certainty Clinical features convalescent plasma coronavirus coronavirus disease corticoids COVID-19 current therapy drug effective Endocytic pathway endocytosis Epitopes host-virus interaction Hydroxychloroquine identify immune immune response immune system disorders immunosuppressive drug Inflammatory cytokines initial interferons kinase inhibitors Mesenchymal stem cells monoclonal antibodies monoclonal antibody neutralization nucleotide analogue Numerous pandemic pathogenic mechanism pathogenic mechanisms promote Remdesivir RNA-dependent RNA polymerase Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2 vaccine Side effect similarity Spread stem cells Still therapeutic option therapeutic targets therapy Treatment Trial triggered Vaccine virus [DOI] 10.3389/fphar.2020.01224 PMC 바로가기 [Article Type] Pharmacology
Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2Review Published on 2020-05-202022-10-29 Journal: International Journal of Molecular Sciences [Category] COVID-19, MERS, SARS, [키워드] anti-inflammatory compounds Antibiotics antiparasitic agent Antiretrovirals bortezomib caused Cell cellular homeostasis compounds consequence Convalescent patients coronavirus COVID-19 CoVs Deleterious Effect effective endoplasmic stress global pandemic Immunological response in viral inflammatory conditions inhibitor MG132 off-label Oxygen administration Patient plasma proteasome proteasome inhibitors protein expression reduce Replication RNA SARS-CoV-2 subsequent supportive care the cytokine storm therapeutic therapy treated Treatment triggered UPR response virus entry virus replication [DOI] 10.3390/ijms21103622 PMC 바로가기 [Article Type] Review
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral TherapyTAILoR(인간 면역결핍 바이러스[HIV]의 TelmisArtan 및 InsuLin 내성): 복합 항레트로바이러스 요법을 받는 HIV 양성 환자의 인슐린 내성 감소를 위한 Telmisartan의 적응형 설계, 용량 범위 IIb상 무작위 시험Articles and Commentaries Published on 2020-05-152022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] adaptive Analysis antiretroviral drugs Antiretroviral therapy Antiretrovirals ARMS cardiovascular disease check clinical Combination conducted Controlled trial demonstrated Efficacy evaluated fat had no HIV HIV infection homeostasis Human Human immunodeficiency virus identify IIb immunodeficiency virus improvement Improvements index individual Infection insulin insulin resistance Insulin sensitivity interim analysis Intervention investigated ISRCTN liver longitudinal longitudinal analysis measure metabolic abnormalities Metabolic abnormality metabolic disease morbidity and mortality multicenter no difference no differences no significant effect once daily Open-label participant Patient phase plasma Primary outcome primary outcome measure Randomized receiving recruited reduce reduction in Registration resistance Result risk secondary outcome measures significant effect Stage stage II telmisartan Trial with HIV [DOI] 10.1093/cid/ciz589 PMC 바로가기 [Article Type] Articles and Commentaries
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessmentReview Published on 2020-04-012022-10-31 Journal: Journal of the International AIDS Society [Category] COVID-19, SARS, [키워드] antiretroviral antiretroviral drug Antiretroviral therapy Antiretrovirals benefit caused certainty of evidence Clinical improvement Clinical outcome clinical trials control group coronavirus COVID‐19 COVID‐19 database Efficacy and safety Evidence high risk HIV improve clinical outcome Infection initial limited sample size MERS Mortality observational study outcome outcomes Patient patients with SARS Prevent Prophylaxis protective effect provided Randomized randomized trial receive reported Result SARS SARS‐CoV‐2 screened Standard of care statistically significant statistically significant difference Symptom the disease treated Treatment Trial [DOI] 10.1002/jia2.25489 PMC 바로가기 [Article Type] Review
Antiretroviral Effects on HBV/HIV Co-infection and the Natural History of Liver DiseaseReview Published on 2019-08-012023-06-18 Journal: Clinics in Liver Disease [Category] B형 간염, [키워드] Antiretrovirals HAART HBV HIV natural history [DOI] 10.1016/j.cld.2019.04.004 [Article Type] Review
Stock-outs! Improvisations and processes of infrastructuring in Uganda’s HIV/Aids and malaria programmesarticle Published on 2018-03-312024-09-01 Journal: Global Public Health [Category] 말라리아, [키워드] Antiretrovirals Improvisations Infrastructure malaria Stock-outs Uganda [Article Type] article
Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds항레트로바이러스 화합물에 의한 말라리아 간 감염 억제Original Research Published on 2017-07-192024-08-12 Journal: Frontiers in Cellular and Infection Microbiology [Category] 말라리아, [키워드] AIDS Antiretroviral therapy Antiretrovirals HIV liver stage malaria Plasmodium [DOI] 10.3389/fcimb.2017.00329 PMC 바로가기 [Article Type] Original Research